Key result
Apelin-13 protects against endothelial apoptosis via the AMPK pathway, suggesting potential for diabetic cardiovascular complications.
Why the study?
Methylglyoxal induces endothelial dysfunction via ER stress and unfolded protein responses, but the molecular mechanisms and protective effects of apelin-13 are unclear.
Answers are grounded in this paper and cite their sources.
MGO-induced endothelial ER stress is hypothesis-generating; leaves open apelin as a potential modulator pending in vivo confirmation.
It has been suggested that methylglyoxal (MGO), a glycolytic metabolite, has more detrimental effects on endothelial dysfunction than glucose itself. Recent reports showed that high glucose and MGO induced endoplasmic reticulum (ER) stress and myocyte apoptosis in ischemic heart disease was inhibited by apelin. The goal of the study is to investigate the molecular mechanism by which MGO induces endothelial dysfunction via the regulation of ER stress in endothelial cells, and to examine whether apelin-13, a cytoprotective polypeptide ligand, protects MGO-induced aortic endothelial dysfunction. MGO-induced ER stress and apoptosis were determined by immunoblotting and MTT assay in HUVECs. Aortic endothelial dysfunction was addressed by en face immunostaining and acetylcholine-induced vasodilation analysis with aortic rings from mice treated with MGO in the presence or absence of apelin ex vivo. TUDCA, an inhibitor of ER stress, inhibited MGO-induced apoptosis and reduction of cell viability, suggesting that MGO signaling to endothelial apoptosis is mediated via ER stress, which leads to activation of unfolded protein responses (UPR). In addition, MGO-induced UPR and aortic endothelial dysfunction were significantly diminished by apelin-13. Finally, this study showed that apelin-13 protects MGO-induced UPR and endothelial apoptosis through the AMPK pathway. Apelin-13 reduces MGO-induced UPR and endothelial dysfunction via regulating the AMPK activating pathway, suggesting the therapeutic potential of apelin-13 in diabetic cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2020) studied Endothelial dysfunction. Apelin-13 vs. Absence of apelin was evaluated on MGO-induced unfolded protein responses (UPR) and endothelial apoptosis/dysfunction. Apelin-13 protects against methylglyoxal-induced unfolded protein responses and endothelial apoptosis through the AMPK pathway, suggesting therapeutic potential in diabetic cardiovascular complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: